The first thing would be to list COVID-19 treatments and vaccines under schedule 1 of the Patent Act and support the TRIPS waiver.
What for me is very important.... Basically, we had massive public subsidies and advanced market agreements in order to make sure that we were de-risking investment to make sure we moved as fast as possible.
We need to make sure that these alternatives to patents can be used when necessary. When countries get together, it's just, “Okay, we will be publicly and massively funding this,” but then they should not stick with structures where the production of scarcity is central to the profitability of some of the stakeholders.